Themis Medicare share news, announcements and annual reports
NSE: THEMISMEDBSE: 530199Pharmaceuticals & BiotechnologySmall Cap
Themis Medicare Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Apr 2007 on NSE
Last close ₹94.83down ₹2.69 (2.76%)BSE ₹95.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹97.52.
30 Oct: open ₹97.39, high ₹99.58, low ₹94.02
52-week range of traded prices to 30 Oct 2026
₹64.95Low, 30 Mar 2026₹140.60High, 7 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹873 Cr1,570th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.85
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.19
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹92 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −13.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,90035.0% delivered
Themis Medicare board meetings
167 filed, newest first. Page 4 of 4.
Apr 2009
30 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 30, 2009, inter alia, has considered the following: 1) Approved a Scheme of Arrangement between the Company and its Members and Appointed Date being March 31, 2009. 2) Under the proposed Scheme a "Reconstruction Reserve Account" will be created by transferring aggregate value of all reserves including reserve created by revaluation of land at Vapi, Hyderabad and Haridwar factories of the Company. The reconstruction reserve account will be utilized to write off specified assets of the Company. The residuary balance in the reconstruction reserve account shall stand credited to general reserve in the books of the Company. 3) The Scheme will be, subject to requisite consent and approval from members, Gujarat High Court, Stock Exchanges and other statutory authorities as may be required.25 Apr · Board meeting
To discuss scheme of arrangement between the Company and its members under section 391 read with section 78, 100 and other applicable provisions of the Companies Act, 1956.8 Apr · Board meeting
Meeting of the Board of Directors of the Company was held on April 07, 2009 to discuss scheme of arrangement between the Company and its members under section 391 read with section 78, section 100 and other applicable provisions of the Companies Act, 1956. The Board reviewed the aforesaid matter and decided to defer the same for the time being. The Board also appointed Mr. Gabor Gulacsi as an Alternate Director to Mr. Erik Bogsch.
Mar 2009
31 Mar · Board meeting
Meeting of Board of Directors will be held on April 07, 2009 preceded by a meeting of the Audit Committee, to discuss scheme of arrangement between the Company and its members under section 391 read with section 78, 100 and other applicable provisions of the Companies Act, 1956.13 Mar · Board meeting
To discuss normal business agenda.
Jan 2009
21 Jan · Board meeting
Meeting of the Board of Directors of the Company will be held on January 30, 2009 preceded by a meeting of the Audit Committee, to consider, inter alia, the unaudited Financial Results for the quarter ended December 31, 2008.
Oct 2008
14 Oct · Board meeting
Meeting of the Board of Directors of the Company will be held on October 25, 2008 preceded by a meeting of the Audit Committee, to consider, inter alia, the unaudited Financial Results for the year ended September 30, 2008.6 Oct · Board meeting
Board, at its meeting held on October 03, 2008, considered and approved the proposal for acceptance of Public Deposits, by the company. The Board also considered and accepted the resignation of Shri K.T. Lakdawala, from the Director of the company.
Sep 2008
26 Sep · Board meeting
For considering a proposal of Acceptance of Public Deposits.
Jul 2008
14 Jul · Board meeting
To consider and approve inter alia, the Unaudited Financial Results together with Limited Review Report submitted by the Statutory Auditors of the Company for the quarter ended June 30, 2008. The Board Meeting will be preceded by Audit Committee Meeting to recommend the Unaudited Financial Results up to June 30, 2008.
Jun 2008
5 Jun · Board meeting
Meeting of the Board of Directors of the Company will be held on June 18, 2008 preceded by a meeting of the Audit Committee, to consider, inter alia, the Audited Financial Results for the year ended March 31, 2008.
Apr 2008
23 Apr · Board meeting
Company has informed that a meeting of the Board of Directors of the Company will be held on May 02, 2008 to discuss normal agenda of the business.
Jan 2008
9 Jan · Board meeting
To consider and approve inter alia, the Unaudited financial Results together with limited review report submitted by the statutory auditors of the company for the quarter ended December 31, 2007. The board meeting will be preceded by Audit Committee Meeting to recommend the Unaudited Financial Results upto December 31, 2007.
Oct 2007
10 Oct · Board meeting
To consider and approve inter alia, the Unaudited Financial Results together with Limited Review Report submitted by the Statutory Auditors of the Company for the half year ended September 30, 2007. The Board Meeting will be preceded by Audit Committee Meeting to recommend the Unaudited Financial Results upto September 30, 2007.
Jul 2007
10 Jul · Board meeting
Meeting on 18 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
21 Jun · Board meeting
To consider, inter alia, the Audited Financial Results for the year ended March 31, 2007.
Apr 2007
23 Apr · Board meeting
To discuss the routine agenda of the business.